Edition:
United States

Soleno Therapeutics Inc (SLNO.OQ)

SLNO.OQ on NASDAQ Stock Exchange Capital Market

2.10USD
4:00pm EDT
Change (% chg)

$0.13 (+6.60%)
Prev Close
$1.97
Open
$2.00
Day's High
$2.13
Day's Low
$1.99
Volume
3,727
Avg. Vol
7,447
52-wk High
$3.70
52-wk Low
$1.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 0.674
Sep '17 0.00 -0.237
Jun '17 0.00 -0.305
Mar '17 0.00 -0.241
FY 2016 Dec '16 0.00 -1.591
Sep '16 0.00 -0.564
Jun '16 0.00 -0.762
Mar '16 0.00 -0.643
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.14 0.14 0.14 2.50
Quarter Ending Sep-18 1 0.15 0.15 0.15 2.83
Year Ending Dec-18 1 0.44 0.44 0.44 0.75
Year Ending Dec-19 1 1.50 1.50 1.50 1.50
Earnings (per share)
Quarter Ending Jun-18 1 -0.19 -0.19 -0.19 -0.45
Quarter Ending Sep-18 1 -0.21 -0.21 -0.21 -0.50
Year Ending Dec-18 1 -0.82 -0.82 -0.82 -1.95
Year Ending Dec-19 1 -0.77 -0.77 -0.77 -2.45
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 39.03 32.90
P/E High - Last 5 Yrs. -- 41.30 47.21
P/E Low - Last 5 Yrs. -- 24.83 24.78
Beta 4.98 0.78 0.79
Price to Sales (TTM) -- 7.57 8.29
Price to Book (MRQ) 1.43 8.28 4.33
Price to Tangible Book (MRQ) 6.36 16.82 5.85
Price to Cash Flow (TTM) 258.83 25.84 21.98
% Owned Institutions 62.21 4.19 2.41

Dividends

  Company industry sector
Dividend Yield -- 0.87 1.65
Dividend Yield - 5 Year Avg -- 1.08 0.80
Dividend 5 Year Growth Rate -- 17.71 4.07
Payout Ratio(TTM) -- 19.24 17.46

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 10.23 4.91
Sales (TTM) vs TTM 1 Yr. Ago -- 12.03 12.76
Sales - 5 Yr. Growth Rate -- 10.04 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 142.34 18.12 35.43
EPS (TTM) vs TTM 1 Yr. Ago 97.72 -- --
EPS - 5 Yr. Growth Rate -- 15.68 8.55
Capital Spending - 5 Yr. Growth Rate 0.63 7.11 8.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.16 2.53
Current Ratio (MRQ) 10.38 2.78 3.60
LT Debt to Equity (MRQ) 0.00 24.66 12.91
Total Debt to Equity (MRQ) 0.00 31.32 15.97
Interest Coverage (TTM) -- 24.54 34.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 100.00 57.94 54.97
Gross Margin - 5 Yr. Avg. -- 57.90 52.78
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -949.36 24.03 15.93
Operating Margin (TTM) -- 19.10 0.12
Operating Margin - 5 Yr. Avg. -1,071.71 16.76 11.20
Pre-Tax Margin (TTM) -- 18.76 2.20
Pre-Tax Margin - 5 Yr. Avg. -1,495.57 16.54 11.41
Net Profit Margin (TTM) -- 14.52 -1.22
Net Profit Margin - 5 Yr. Avg. -1,155.62 11.61 7.70
Effective Tax Rate (TTM) -- 12.49 31.30
Effective Tax Rate - 5 Yr. Avg. -- 27.95 24.62

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 887,170 731,572,994
Net Income/Employee (TTM) -- 135,886 85,104,893
Receivable Turnover (TTM) -- 4.83 5.75
Inventory Turnover (TTM) -- 3.27 3.58
Asset Turnover (TTM) 0.00 0.76 0.86

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -6.55 10.79 10.07
Return on Assets - 5 Yr. Avg. -93.65 9.47 11.12
Return on Investment (TTM) -7.10 14.34 12.74
Return on Investment - 5 Yr. Avg. -238.07 12.32 14.40
Return on Equity (TTM) -9.75 17.21 14.64
Return on Equity - 5 Yr. Avg. -- 14.89 15.76
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 95.14 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Soleno Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 62.21%
# of Holders: 17
Total Shares Held: 12,297,883
3 Mo. Net Change: 144,406
# New Positions: 3
# Closed Positions: 4
# Increased Positions: 8
# Reduced Positions: 5
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.